References
- Hawton K, Simkin S, Deeks J. Co-proxamol and suicide: a study of national mortality statistics and local non-fatal self poisonings. BMJ 2003; 326:1006–1008., [PUBMED], [INFOTRIEVE]
- Bateman D N. Opioids. Medicine the Continously Updated Resource of Clinical Medicine. The Medicine Publishing Company Ltd., 2003:64–66.
- Bateman D N, Afshari R. Co-proxamol and suicide: licence needs to be changed. BMJ 2003; 327:287., [PUBMED], [INFOTRIEVE], [CROSSREF]
- British National Formulary45th ed. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain, 2003.
- Schiodt F V, Ott P, Christensen E, Bondesen S. The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage. Clin Pharmacol Ther 2002; 71:221–225., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- British National Formulary. 45th ed. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain, 2003.
- Nickander R C, Emmerson J L, Hynes M D, Steinberg M I, Sullivan H R. Pharmacologic and toxic effects in animals of dextropropoxyphene and its major metabolite norpropoxyphene: a review. Human Toxicol 1984; 3(suppl):13S–36S.
- Whitcomb D C, Gilliam F R III, Starmer C F, Grant A O. Marked QRS complex abnormalities and sodium channel blockade by propoxyphene reversed with lidocaine. J Clin Invest 1989; 84:1629–1636., [PUBMED], [INFOTRIEVE], [CSA]
- Holland D R, Steinberg M I. Electrophysiologic properties of propoxyphene and norpropoxyphene in canine cardiac conducting tissues in vitro and in vivo. Toxicol Appl Pharmacol 1979; 47:123–133., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Amsterdam E A, Rendig S V, Henderson G L, Mason D T. Depression of myocardial contractile function by propoxyphene and norpropoxyphene. J Cardiovasc Pharmacol 1981; 3:129–138., [PUBMED], [INFOTRIEVE]
- Hondeghem L M, Katzung B G. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta 1977; 472:373–398., [PUBMED], [INFOTRIEVE]
- Bredgaard S M, Strom J, Sloth M P, Angelo H R, Reiz S. Haemodynamic, electrocardiographic and cardiometabolic changes after overdose of propoxyphene. An experimental study in pentobarbitone-anaesthetized pigs. Human Toxicol 1984; 3(suppl):53S–59S.
- Bredgaard S M, Haggmark S, Nyhman H, Sloth M P, Strom J, Reiz S. Circulatory shock following intravenous propoxyphene poisoning. An experimental study of cardiac function and metabolism in pentobarbital-anesthetized pigs. Acta Anaesthesiol Scand 1985; 29:130–136.
- Lund-Jacobsen H. Cardio-respiratory toxicity of propoxyphene and norpropoxyphene in conscious rabbits. Acta Pharmacol Toxicol (Copenh) 1978; 42:171–178.
- Stork C M, Redd J T, Fine K, Hoffman R S. Propoxyphene-induced wide QRS complex dysrhythmia responsive to sodium bicarbonate—a case report. J Toxicol, Clin Toxicol 1995; 33:179–183.
- Afshari R, Bateman D N. ECG abnormalities in co-proxamol (paracetamol/dextropropoxyphene) poisoning. J Toxicol, Clin Toxicol 2003; 41.
- Proudfoot A T. Clinical features and management of distalgesic overdose. Human Toxicol 1984; 3(suppl):85S–94S.
- Buckley B M, Vale J A. Dextropropoxyphene poisoning: problems with interpretation of analytical data. Human Toxicol 1984; 3(suppl):95S–101S.
- Rodda B E, Scholz N E, Gruber C M Jr, Wolen R L. Evaluation of plasma concentrations of propoxyphene utilizing a hybrid principal component-analysis of variance technique. Case 1–equimolar doses. Toxicol Appl Pharmacol 1971; 19:554–562., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Verebely K, Inturrisi C E. Disposition of propoxyphene and norpropoxyphene in man after a single oral dose. Clin Pharmacol Ther 1974; 15:302–309., [PUBMED], [INFOTRIEVE]
- Schou J, Angelo H, Dam W, Jensen K, Christensen J M. Pharmacokinetics of dextropropoxyphene in acute poisoning. Arch Toxicol 1978; 1: 343–346.
- Pearson R M. Pharmacokinetics of propoxyphene. Human Toxicol 1984; 3(suppl):37S–40S.
- Crome P, Gain R, Ghurye R, Flanagan R J. Pharmacokinetics of dextropropoxyphene and nordextropropoxyphen1e in elderly hospital patients after single and multiple doses of distalgesic. Preliminary analysis of results. Human Toxicol 1984; 3(suppl):41S–48S.
- Gram L F, Schou J, Way W L, Heltberg J, Bodin N O. d-Propoxyphene kinetics after single oral and intravenous doses in man. Clin Pharmacol Ther 1979; 26:473–482., [PUBMED], [INFOTRIEVE]
- Ansel G M, Coyne K, Arnold S, Nelson S D. Mechanisms of ventricular arrhythmia during amitriptyline toxicity. J Cardiovasc Pharmacol 1993; 22:798–803., [PUBMED], [INFOTRIEVE]
- Lavoie F W, Gansert G G, Weiss R E. Value of initial ECG findings and plasma drug levels in cyclic antidepressant overdose. Ann Emerg Med 1990; 19:696–700., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Niemann J T, Bessen H A, Rothstein R J, Laks M M. Electrocardiographic criteria for tricyclic antidepressant cardiotoxicity. Am J Cardiol 1986; 57:1154–1159., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jonasson B, Jonasson U, Saldeen T. Among fatal poisonings dextropropoxyphene predominates in younger people, antidepressants in the middle aged and sedatives in the elderly. J Forensic Sci 2000; 45:7–10., [PUBMED], [INFOTRIEVE]
- Whittington R M. Dextropropoxyphene deaths: coroner's report. Human Toxicol 1984; 3(suppl):175S–185S.